Hookipa Pharma Inc (NASDAQ:HOOK) price is hovering lower on Monday, November 20, dropping -2.70% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $0.52, with intraday deals fluctuating between $0.461 and $0.54. The company’s 5Y monthly beta was ticking 0.74. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.05 and 52-week low of $0.41. The stock added 6.50% on its value in the past month.
Hookipa Pharma Inc, which has a market valuation of $42.39 million, is expected to release its quarterly earnings report Nov 09, 2023.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give HOOK a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that HOOK’s price is at present 10.82% off the SMA20 and -6.22% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 53.33, with weekly volatility standing at 9.42%. The indicator jumps to 10.40% when calculated based on the past 30 days. Hookipa Pharma Inc (NASDAQ:HOOK)’s beta value is holding at 0.82, while the average true range (ATR) indicator is currently reading 0.05.
An analysis of the Hookipa Pharma Inc (NASDAQ:HOOK) stock in terms of its daily trading volume indicates that the 3-month average is 320.49K. However, this figure increases on the past 10-day timeline to an average of 0.26 million.
Current records show that the company has 83.95M in outstanding shares. The insiders’ percentage holdings are 11.42% of outstanding shares while the percentage share held by institutions stands at 49.50%. The stats also highlight that short interest as of Oct 30, 2023, stood at 0.31 million shares, which puts the short ratio at the time at 0.93. From this we can glean that short interest is 0.37% of company’s current outstanding shares. Notably, we see that shares short in October fall slightly given the previous month’s figure stood at 0.4 million. But the -37.65% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.